Nippon India Pharma Fund Direct Bonus
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Pharma Fund Direct Bonus
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 01-Jan-2013
Fund Manager
: Sailesh Raj Bhan
Net Assets (Rs. cr)
: 8306.35
Nippon India Pharma Fund Direct Bonus - Nav Details
Nav Date
: 13-Mar-2026
NAV [Rs.]
: 563.6405
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
:
Exit Load %
:
Nippon India Pharma Fund Direct Bonus- NAV Chart
Nippon India Pharma Fund Direct Bonus- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | -1.47 | 0.17 | -1.64 | -2.61 | 9.39 | 24.85 | 16.22 | 17.08 |
| Category Avg | -1.64 | -0.13 | -2.78 | -4.41 | 8.5 | 24.55 | 15.56 | 12.39 |
| Category Best | -0.58 | 2.52 | 1.06 | -0.19 | 14.22 | 28.62 | 18.27 | 26.05 |
| Category Worst | -3.29 | -2.33 | -6.19 | -8.33 | 1.61 | 19.81 | 11.57 | -6.91 |
Nippon India Pharma Fund Direct Bonus- Latest Dividends
No Records Found
Nippon India Pharma Fund Direct Bonus- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 13.08 | 6256349 | 1,086.72 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 7.99 | 2883991 | 663.86 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 6.56 | 850754 | 545.20 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 5.81 | 3749746 | 482.32 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 5.67 | 3495054 | 471.20 |
| Equity | Apollo Hospitals | Healthcare Services | 5.17 | 548795 | 429.24 |
| Equity | Medplus Health | Retailing | 3.70 | 3627277 | 307.44 |
| Equity | Max Healthcare | Healthcare Services | 3.49 | 2658082 | 290.24 |
| Equity | Vijaya Diagnost. | Healthcare Services | 3.49 | 2886684 | 289.96 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 3.41 | 946323 | 283.31 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 3.07 | 2555745 | 255.12 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 3.06 | 1131195 | 254.24 |
| Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 2.83 | 913226 | 234.84 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.51 | 1364742 | 208.65 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.50 | 1702630 | 207.78 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 2.37 | 74187 | 196.81 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 2.20 | 323678 | 182.53 |
| Equity | Thyrocare Tech. | Healthcare Services | 2.08 | 4392120 | 172.89 |
| Equity | Dr Lal Pathlabs | Healthcare Services | 2.05 | 1218224 | 170.53 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 1.98 | 799649 | 164.20 |
| Equity | Pfizer | Pharmaceuticals & Biotechnology | 1.94 | 318249 | 161.10 |
| Equity | Narayana Hrudaya | Healthcare Services | 1.82 | 823911 | 150.84 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 1.76 | 800549 | 145.87 |
| Equity | Emcure Pharma | Pharmaceuticals & Biotechnology | 1.31 | 746337 | 108.62 |
| Equity | Suraksha Diagno. | Healthcare Services | 1.27 | 3896349 | 105.76 |
| Equity | Fortis Health. | Healthcare Services | 1.25 | 1103889 | 104.05 |
| Equity | Sanofi Consumer | Pharmaceuticals & Biotechnology | 1.15 | 213659 | 95.91 |
| Equity | Sanofi India | Pharmaceuticals & Biotechnology | 1.10 | 230272 | 91.30 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 1.04 | 2219374 | 86.51 |
| Equity | Syngene Intl. | Healthcare Services | 0.96 | 1883372 | 79.51 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 0.89 | 1058503 | 74.22 |
| Equity | Akums Drugs | Pharmaceuticals & Biotechnology | 0.89 | 1515264 | 73.96 |
| Equity | Astrazeneca Phar | Pharmaceuticals & Biotechnology | 0.67 | 62568 | 55.36 |
| Equity | Indoco Remedies | Pharmaceuticals & Biotechnology | 0.45 | 1834924 | 37.11 |
| Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 0.16 | 111738 | 13.63 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
7,11,597.56
Trustee/s:
Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
